Fertility After Uterine Artery Embolization

Status Recruiting

Clinical Trial Summary

Uterine leiomyomas (or fibroids) are a common disease (30% of women over 35 years of age) in women of childbearing age and can cause various symptoms such as menometrorrhagia, dysmenorrhoea, pelvic pain and heaviness, and infertility. Uterine artery embolisation, first used in France in 1990, is a safe, effective and less invasive therapeutic technique than surgical treatment (myomectomy or hysterectomy), particularly in the case of numerous and large fibroids. This technique is validated by the French National College of Gynaecologists-Obstetricians (CNGOF) as an alternative treatment for women who do not wish to become pregnant (grade A recommendation), but at present there is little reliable data concerning fertility, the occurrence of pregnancy and the obstetrical prognosis after uterine artery embolisation for fibroids. A recent systematic review of the literature with meta-analysis published very recently showed that 40.5% of patients with a desire for pregnancy were able to become pregnant after embolisation (CI: 33.3%-48.2%) but that the rates of miscarriage, obstetric complications and low birth weight were not negligible (respectively 33.5% (95% CI: 26.3-41%), 25.4% (95% CI = 13-40.2%) and 10% (95% CI = 6.2-14.6%) (Ghanaati et al. 2020). In France, uterine artery embolisation is performed in more than thirty centres in women who have completed their parental project. On the other hand, in the absence of consistent literature, it is performed in patients of childbearing age, when it represents the only acceptable alternative or in the event of contraindication or refusal of surgery by the patient. To our knowledge, there is no large-scale French study to date on the impact of embolisation on fertility and pregnancy outcomes. The aim of this study is to compile a retrospective database of all cases of uterine artery embolisation for uterine pathology performed at the Georges-Pompidou European Hospital (HEGP) since 2007 and to assess the impact of embolisation on fertility in patients of childbearing age.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05271981
Study type	Observational
Source	Assistance Publique - Hôpitaux de Paris
Contact	Natacha Nohilé
Phone	331 56 09 59 82
Email	natacha.nohile@aphp.fr
Status	Recruiting
Phase
Start date	November 23, 2022
Completion date	November 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05634850` - Evaluating the Usability of the Product Kinder System Trial, Home Based Hormone for In-Vitro Fertilization (IVF) Monitoring System.
Completed	`NCT03803228` - Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders	Phase 3
Active, not recruiting	`NCT06053827` - Natural Frozen Embryo Transfer (FET) vs Substituted Frozen Embryo Transfer (FET)
Recruiting	`NCT03480412` - Second Step Protocol in Poor Ovarian Responder (POR)
Not yet recruiting	`NCT04606082` - Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor in Increasing Pregnancy Rate in ICSI	N/A
Not yet recruiting	`NCT04604054` - The Effect of Granulocyte Colony Stimulating Factor Versus Human Chorionic Gonadotropin in Females With a History of RIF	N/A
Not yet recruiting	`NCT04589793` - COaching Lifestyle Intervention for FErtility	N/A
Completed	`NCT06441409` - Serum Ferritin Levels and Metabolic Dysfunction Associated Steatotic Liver Disease	N/A
Completed	`NCT03846544` - Double Pick up in Poor Prognosis Women	Phase 4
Completed	`NCT04141436` - Hypnofertility for Women Undergoing In Vitro Fertilization (HWUIVF)	N/A
Completed	`NCT03161873` - Cycle and Pregnancy Monitoring With Wearable Sensor Technology (AVA)
Completed	`NCT03007043` - Genetic Variation in Gonadotropin and Gonadotropin Receptor Genes and Suboptimal Response
Completed	`NCT04133402` - Fertility After Intrauterine Tamponing Balloon: Where Are we
Active, not recruiting	`NCT06128395` - ASA 81 mg vs 162 mg During Frozen Embryo Transfer (FET)
Recruiting	`NCT05807256` - Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases
Completed	`NCT03908697` - Quantum Natural Family Planning Pilot	N/A
Completed	`NCT04908774` - Effects of a Fasting Mimicking Diet on Sperm Quality	N/A
Recruiting	`NCT05205733` - Expanding Fertility Care to Poor and Low Resourced Settings Study	N/A
Active, not recruiting	`NCT03085212` - Strategies for Pregnancy Achievement	N/A
Completed	`NCT01388907` - Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Fertility After Uterine Artery Embolization — FERTI-EMBOL

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms